Mycobacterium Citations List: December 2022

Literature Citations

1. Novel Diaryl Ether Derivatives as InhA Inhibitors: Design, Synthesis and Antimycobacterial Activity. Abdelaziz, O.A., D.I.A. Othman, M.M. Abdel-Aziz, S.M.I. Badr, and H.M. Eisa. Bioorganic Chemistry, 2022. 129: 106125. PMID[36126606].
[PubMed]. TB_12_2022.

2. Development of Novel Isatin-tethered Quinolines as Anti-tubercular Agents against Multi and Extensively Drug-resistant Mycobacterium tuberculosis. Abdelrahman, M.A., H. Almahli, T. Al-Warhi, T.A. Majrashi, M.M. Abdel-Aziz, W.M. Eldehna, and M.A. Said. Molecules, 2022. 27(24): 8807. PMID[36557937]. PMCID[PMC9781264].
[PubMed]. TB_12_2022.

3. In Vitro and in Vivo Activity of Gepotidacin against Drug-resistant Mycobacterial Infections. Ahmad, M.N., T. Garg, S. Singh, R. Shukla, P. Malik, R.V. Krishnamurthy, P. Kaur, S. Chopra, and A. Dasgupta. Antimicrobial Agents and Chemotherapy, 2022. 66(12): e0056422. PMID[36445129]. PMCID[PMC9765166].
[PubMed]. TB_12_2022.

4. Coumarin hydrazone oxime Scaffolds as Potent Anti-tubercular Agents: Synthesis, X-ray Crystal and Molecular Docking Studies. Akki, M., D.S. Reddy, K.S. Katagi, A. Kumar, H.C. Devarajegowda, M.S. Kumari, V. Babagond, and S.D. Joshi. ChemistrySelect, 2022. 7(46): e202203260. ISI[000894364100001].
[WOS]. TB_12_2022.

5. Discovery of Biphenyls Bearing Thiobarbiturate Fragment by Structure-based Strategy as Mycobacterium tuberculosis Protein Tyrosine phosphatase B Inhibitors. Cheng, S., Q. Wang, X. Chen, J. Chen, B. Wang, D. Chen, D. Shen, J. Tian, F. Ye, Y. Lu, H. Huang, Y. Lu, and D. Zhang. Bioorganic & Medicinal Chemistry, 2022. 73: 117006. PMID[36150342].
[PubMed]. TB_12_2022.

6. Tricyclic Spirolactams Kill Mycobacteria in Vitro and in Vivo by Inhibiting Type II NADH dehydrogenases. Dam, S., S. Tangara, C. Hamela, T. Hattabi, L. Faïon, P. Carre, R. Antoine, A. Herledan, F. Leroux, C. Piveteau, M. Eveque, M. Flipo, B. Deprez, L. Kremer, N. Willand, B. Villemagne, and R.C. Hartkoorn. Journal of Medicinal Chemistry, 2022. 65(24): p. 16651-16664. PMID[36473699]. PMCID[PMC9791652].
[PubMed]. TB_12_2022.

7. Benzo[d]thiazole-2-carboxamides as New Antituberculosis Chemotypes Inhibiting Mycobacterial ATP phosphoribosyl transferase. Dhameliya, T.M., R. Tiwari, A. Banerjee, S. Pancholia, D. Sriram, D. Panda, and A.K. Chakraborti. Future Medicinal Chemistry, 2022. 14(24): p. 1847-1864. PMID[36444737].
[PubMed]. TB_12_2022.

8. Synthesis, Structural Characterization and Biological Activity Evaluation of Novel Cu(II) Complexes with 3-(Trifluoromethyl)phenylthiourea Derivatives. Drzewiecka-Antonik, A., M. Struga, A. Głogowska, E. Augustynowicz-Kopec, K. Dobrzyńska, A. Chrzanowska, A. Wolska, P. Rejmak, M.T. Klepka, M. Wrzosek, and A. Bielenica. International Journal of Molecular Sciences, 2022. 23(24): 15694. PMID[36555333]. PMCID[PMC9779606].
[PubMed]. TB_12_2022.

9. Similarity-based Virtual Screening to Find Antituberculosis Agents Based on Novel Scaffolds: Design, Syntheses and Pharmacological Assays. García-García, Á., J.V. Julián-Ortiz, J. Gálvez, D. Font, C. Ayats, M.D.R. Guna Serrano, C. Muñoz-Collado, R. Borrás, and J.M. Villalgordo. International Journal of Molecular Sciences, 2022. 23(23): 15057. PMID[36499384]. PMCID[PMC9737236].
[PubMed]. TB_12_2022.

10. Ethionamide and Prothionamide Based Courmarinyl-thiazole Thiazole Derivatives: Synthesis, Antitubercular Activity, Toxicity Investigations and Molecular Docking Studies. Imran, M. Pharmaceutical Chemistry Journal, 2022. 56(9): p. 1215-1225. PMID[36531826]. PMCID[PMC9734486].
[PubMed]. TB_12_2022.

11. In Vitro Antimycobacterial Activity of Human Lactoferrin-derived Peptide, D-hLF 1-11, against Susceptible and Drug-resistant Mycobacterium tuberculosis and Its Synergistic Effect with Rifampicin. Intorasoot, S., A. Intorasoot, A. Tawteamwong, B. Butr-Indr, P. Phunpae, C.S. Tharinjaroen, U. Wattananandkul, S. Sangboonruang, and J. Khantipongse. Antibiotics, 2022. 11(12): 1785. PMID[36551443]. PMCID[PMC9774897].
[PubMed]. TB_12_2022.

12. In Vitro and in Silico Pharmacological and Cosmeceutical Potential of Ten Essential Oils from Aromatic Medicinal Plants from the Mascarene Islands. Jugreet, B.S., N. Lall, I. Anina Lambrechts, A.M. Reid, J. Maphutha, M. Nel, A.H. Hassan, A. Khalid, A.N. Abdalla, B.L. Van, and M.F. Mahomoodally. Molecules, 2022. 27(24): 8705. PMID[36557842]. PMCID[PMC9788324].
[PubMed]. TB_12_2022.

13. Design, Synthesis and Antimicrobial Properties of New Tetracyclic quinobenzothiazine Derivatives. Kisiel-Nawrot, E., D. Pindjakova, M. Latocha, A. Bak, V. Kozik, K. Suwinska, A. Sochanik, A. Cizek, J. Jampilek, and A. Zięba. International Journal of Molecular Sciences, 2022. 23(23): 15078. PMID[36499402]. PMCID[PMC9736374].
[PubMed]. TB_12_2022.

14. Exploring Micromonospora as Phocoenamicins Producers. Kokkini, M., C. González Heredia, D. Oves-Costales, M. de la Cruz, P. Sánchez, J. Martín, F. Vicente, O. Genilloud, and F. Reyes. Marine Drugs, 2022. 20(12): 769. PMID[36547916]. PMCID[PMC9782249].
[PubMed]. TB_12_2022.

15. 2,4-Disubstituted Pyridine Derivatives are Effective against Intracellular and Biofilm-forming Tubercle bacilli. Korycka-Machala, M., M. Kawka, J. Lach, R. Plocinska, A. Bekier, B. Dziadek, A. Brzostek, P. Plocinski, D. Strapagiel, M. Szczesio, K. Gobis, and J. Dziadek. Frontiers in Pharmacology, 2022. 13: 1004632. PMID[36438838]. PMCID[PMC9685343].
[PubMed]. TB_12_2022.

16. Anti-microbial Activity of Aliphatic alcohols from Chinese Black Cardamom (Amomum tsao-ko) against Mycobacterium tuberculosis H37Rv. Lee, S.Y., G.S. Shetye, S.R. Son, H. Lee, L.L. Klein, J.K. Yoshihara, R. Ma, S.G. Franzblau, S. Cho, and D.S. Jang. Plants, 2022. 12(1): 34. PMID[36616162].
[PubMed]. TB_12_2022.

17. In Vitro Profiling of the Synthetic RNA polymerase Inhibitor MMV688845 against Mycobacterium abscessus. Mann, L., U.S. Ganapathy, R. Abdelaziz, M. Lang, M.D. Zimmerman, V. Dartois, T. Dick, and A. Richter. Microbiology Spectrum, 2022. 10(6): e0276022. PMID[36377951]. PMCID[PMC9769904].
[PubMed]. TB_12_2022.

18. Novel 1,2,3-Triazole-Based Benzothiazole Derivatives: Efficient Synthesis, DFT, Molecular Docking, and ADMET Studies. Mirjafary, Z., M. Mohammad Karbasi, P. Hesamzadeh, H.R. Shaker, A. Amiri, and H. Saeidian. Molecules, 2022. 27(23): 8555. PMID[36500647]. PMCID[PMC9740823].
[PubMed]. TB_12_2022.

19. Enhancement of Antimycobacterial Activity of Rifampicin Using Mannose-anchored Lipid Nanoparticles against Intramacrophage Mycobacteria. Mistry, N., R. Bandyopadhyaya, and S. Mehra. ACS Applied Bio Materials, 2022. 5(12): p. 5779-5789. PMID[36441965].
[PubMed]. TB_12_2022.

20. Ursolic acid and Solasodine as Potent Anti-mycobacterial Agents for Combating Paratuberculosis: An Anti-inflammatory and in Silico Analysis. Navabharath, M., V. Srivastava, S. Gupta, S.V. Singh, and S. Ahmad. Molecules, 2022. 28(1): 274. PMID[36615467].
[PubMed]. TB_12_2022.

21. Synergistic Effect of Q203 Combined with PBTZ169 against Mycobacterium tuberculosis. Nguyen, T.Q., B.T.B. Hanh, S. Jeon, B.E. Heo, Y. Park, A. Choudhary, C. Moon, and J. Jang. Antimicrobial Agents and Chemotherapy, 2022. 66(12): e0044822. PMID[36321819]. PMCID[PMC9765072].
[PubMed]. TB_12_2022.

22. Novel 4-Aminoquinolines: Synthesis, Inhibition of the Mycobacterium tuberculosis Enoyl-Acyl Carrier Protein Reductase, Antitubercular Activity, SAR, and Preclinical Evaluation. Paz, J.D., N.D.D. Sperotto, A.S. Ramos, K. Pissinate, V.D. Rodrigues, B.L. Abbadi, A.F. Borsoi, R.S. Rambo, A.C.C. Minotto, A.D. Dadda, L. Galina, F.S.M. Hopf, M.N. Muniz, L.K.B. Martinelli, C.D. Roth, R.B.M. Silva, M.A. Perello, A.D. Czeczot, C.E. Neves, L.S. Duarte, M. Leyser, S.D. de Oliveira, C.V. Bizarro, P. Machado, and L.A. Basso. European Journal of Medicinal Chemistry, 2023. 245: 114908. PMID[36435016].
[PubMed]. TB_12_2022.

23. Mycobacterial Meng: Partial Purification, Characterization, and Inhibition. Pujari, V., K. Rozman, R.K. Dhiman, C.C. Aldrich, and D.C. Crick. ACS Infectious Diseases, 2022. 8(12): p. 2430-2440. PMID[36417754].
[PubMed]. TB_12_2022.

24. A New Benzothiazolthiazolidine Derivative, 11726172, Is Active in Vitro, in Vivo, and against Nonreplicating Cells of Mycobacterium tuberculosis. Salina, E.G., U. Postiglione, L.R. Chiarelli, D. Recchia, M. Záhorszká, A. Lepioshkin, N. Monakhova, A. Pál, A. Porta, G. Zanoni, J. Korduláková, E. Kazakova, D. Sassera, M.R. Pasca, V. Makarov, and G. Degiacomi. mSphere, 2022. 7(6): e0036922. PMID[36377880]. PMCID[PMC9769805].
[PubMed]. TB_12_2022.

25. Mycobacterium tuberculosis DprE1 Inhibitor OPC-167832 Is Active against Mycobacterium abscessus in Vitro. Sarathy, J.P., M.D. Zimmerman, M. Gengenbacher, V. Dartois, and T. Dick. Antimicrobial Agents and Chemotherapy, 2022. 66(12): e0123722. PMID[36350151]. PMCID[PMC9765218].
[PubMed]. TB_12_2022.

26. Synthesis, Characterization, and Antimicrobial Activity Screening of Some Novel 3-(2-(3-(Substituted benzyloxy)oxetan-3-yl)-3-fluorophenoxy)-8-fluoro-2-methylquinoline Derivatives as Potential Antimycobacterial Agents. Shinde, A., S.R. Ugale, Y. Nandurkar, M. Modak, A.P. Chavan, and P.C. Mhaske. ACS Omega, 2022. 7(50): p. 47096-47107. PMID[36570236]. PMCID[PMC9773968].
[PubMed]. TB_12_2022.

27. Antimycobacterial and Anti-inflammatory Activities of Fractions and Substances from Erythrina verna Vell Focusing on Dual Severe TB Treatment Approach. Simao, T., G.V. Aguiar, A.C. Ramos, G.P. Da Silva, M.F. Muzitano, E. Lassounskaia, and R.R. de Oliveira. Anais da Academia Brasileira de Ciencias, 2022. 94(3): e20211032. PMID[36228304].
[PubMed]. TB_12_2022.

28. NSC19723, a Thiacetazone-like Benzaldehyde Thiosemicarbazone Improves the Efficacy of TB Drugs in Vitro and in Vivo. Singh, P., S. Rawat, A.K. Agrahari, M. Singh, S. Chugh, S. Gurcha, A. Singh, K. Abrahams, G.S. Besra, S. Asthana, D.S. Rawat, and R. Singh. Microbiology Spectrum, 2022. 10(6): e0259222. PMID[36314972]. PMCID[PMC9769743].
[PubMed]. TB_12_2022.

29. Trifluoromethylcinnamanilide Michael Acceptors for Treatment of Resistant Bacterial Infections. Strharsky, T., D. Pindjakova, J. Kos, L. Vrablova, P. Smak, H. Michnova, T. Gonec, J. Hosek, M. Oravec, I. Jendrzejewska, A. Cizek, and J. Jampilek. International Journal of Molecular Sciences, 2022. 23(23): 15090. PMID[36499415]. PMCID[PMC9737391].
[PubMed]. TB_12_2022.

30. Natural Products Lysobactin and Sorangicin a Show in Vitro Activity against Mycobacterium abscessus Complex. Sullivan, J.R., J. Yao, C. Courtine, A. Lupien, J. Herrmann, R. Müller, and M.A. Behr. Microbiology Spectrum, 2022. 10(6): e0267222. PMID[36342177]. PMCID[PMC9769517].
[PubMed]. TB_12_2022.

31. Antimycobacterial Activity and Molecular Docking of Methanolic Extracts and Compounds of Marine Fungi from Saldanha and False Bays, South Africa. Tapfuma, K.I., K. Nyambo, F. Adu-Amankwaah, L. Baatjies, L. Smith, N. Allie, M. Keyster, A.G. Loxton, M. Ngxande, R. Malgas-Enus, and V. Mavumengwana. Heliyon, 2022. 8(12): e12406. PMID[36582695]. PMCID[PMC9793266].
[PubMed]. TB_12_2022.

32. Simultaneous Determination of NTB-3119, a Novel Anti-tuberculosis Agent, and Its Major Metabolites in Mouse Plasma by LC-MS/MS and Its Application in Preclinical Pharmacokinetics Study. Wang, X.B., X.L. Lang, F.H. Wang, H.X. Tan, G. Li, P. Li, J.P. Hu, B.L. Wang, and Y. Li. Journal of Pharmaceutical and Biomedical Analysis, 2023. 224: 115172. PMID[36435083].
[PubMed]. TB_12_2022.

33. Nosiheptide Harbors Potent in Vitro and Intracellular Inhbitory Activities against Mycobacterium tuberculosis. Yu, X., R. Zhu, Z. Geng, Y. Kong, F. Wang, L. Dong, L. Zhao, Y. Xue, X. Ma, and H. Huang. Microbiology Spectrum, 2022. 10(6): e0144422. PMID[36222690]. PMCID[PMC9769715].
[PubMed]. TB_12_2022.

34. Synthesis, Biological Evaluation and Computational Studies of New Hydrazide Derivatives Containing 1,3,4-Oxadiazole as Antitubercular Agents. Zampieri, D., S. Fortuna, M. Romano, A. De Logu, G. Cabiddu, A. Sanna, and M.G. Mamolo. International Journal of Molecular Sciences, 2022. 23(23): 15295. PMID[36499618]. PMCID[PMC9735621].
[PubMed]. TB_12_2022.

35. In Vitro Activity of the Sudapyridine (WX-081) against Non-tuberculous Mycobacteria Isolated in Beijing, China. Zhu, R., Y. Shang, S. Chen, H. Xiao, R. Ren, F. Wang, Y. Xue, L. Li, Y. Li, N. Chu, and H. Huang. Microbiology Spectrum, 2022. 10(6): e0137222. PMID[36250885]. PMCID[PMC9769519].
[PubMed]. TB_12_2022.

Patent Citations

This month, no relevant Mycobacterium patents were identified.